« Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome SSC Lupus Anticoagulant » RecommandationsPar SFTH5 mars 2024
« Peri‐procedure management of antithrombotic agents and thrombocytopenia for common procedures in oncology SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Assays to quantify fibrinolysis: strengths and limitations SSC fibrinolysis » RecommandationsPar SFTH5 mars 2024
« Sepsis-induced coagulopathy in the management of sepsis SSC ISTH » RecommandationsPar SFTH5 mars 2024
« Recommendation on the nomenclature for anticoagulants SSC Control of Anticoagulation » RecommandationsPar SFTH5 mars 2024
« Anticoagulation in adult patients supported with extracorporeal membrane oxygenation (ECMO SSC Perioperative and Critical Care Haemostasis and Thrombosis » RecommandationsPar SFTH5 mars 2024
ISTH guidelines for treatment of thrombotic thrombocytopenic purpura RecommandationsPar SFTH5 mars 2024
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura RecommandationsPar SFTH5 mars 2024
Laboratory assays of VWF activity and use of desmopressin trials in the diagnosis of VWD: a systematic review and meta-analysis RecommandationsPar SFTH5 mars 2024